
Amsterdam UMC doctors target lung tumours without invasive surgery
New non-surgical lung cancer procedure for hard-to-reach tumours
Amsterdam’s life sciences and health (LSH) sector maintains its position as a European hub for medical innovation with its latest breakthrough at Amsterdam UMC. The academic hospital has become the first in the Netherlands and the European Union to offer a new, minimally invasive treatment for small lung tumours: bronchoscopic microwave ablation.
This technique, developed in collaboration with London’s Royal Brompton Hospital, uses a thin tube (bronchoscope) guided through the airways to target lung tumours with precise microwaves, heating and destroying cancerous cells without the need for open surgery. The result is a faster, less stressful experience for patients, with quicker recovery times and fewer complications.
The new treatment specifically benefits patients with small, hard-to-reach tumours deep within the lungs. As well as those who cannot undergo surgery due to existing health conditions. Using advanced imaging to locate the tumour, doctors can safely and effectively remove it in a day procedure, a significant step toward less invasive cancer care.
Amsterdam UMC’s work forms part of a wider vision for the future of lung cancer treatment, including ongoing research into a “one-stop-shop” care model. This would enable diagnosis and treatment in a single session, reducing stress and improving outcomes for patients.
Innovation with global impact in Amsterdam
Amsterdam’s life sciences and health sector has grown quickly in recent years, thanks to a supportive business environment, access to international talent, and strong partnerships between hospitals, universities, and companies.
With only London and now Amsterdam offering this advanced lung cancer treatment, the achievement highlights the Amsterdam region’s ability to lead on the European stage. New treatments like bronchoscopic microwave ablation show how the Dutch city collaborates internationally to develop patient-friendly medical innovations, helping people locally while also attracting attention and partnerships from around the world.
Related articles

New research and diagnostics centre ADORE opens in Amsterdam

Amsterdam’s ADORE Secures €9M to tackle cancer and neurodegenerative diseases

ERC advanced grants awarded to multiple Amsterdam knowledge institutes

Amsterdam UMC leads €12 million lung cancer research project

Amsterdam’s Seenons earns B Corp certification

Hello Tomorrow Global Summit moving to Amsterdam in 2026

The Netherlands has ranked 8th in the Global Innovation Index 2024

United Repair Centre and Levi’s launch denim repair service

EU Commission approves €1.2bn Dutch scheme for industrial decarbonisation
